Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
19 "Palliative care"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Psychometric Validation of Sheffield Profile for Assessment and Referral to Care (SPARC) in Korean Cancer Patients
Hong Jun Kim, Eun Hee Jung, Jung Hye Kwon, Yu Jung Kim, Su-Jin Koh, Myung Ah Lee, Jung Hun Kang, Sun Young Rha, Eun Mi Nam, Sun Kyung Baek, Ha Yeon Lee, Hun Ho Song, Young-Woong Won, Hanbyul Lee
Received July 26, 2024  Accepted December 4, 2024  Published online December 5, 2024  
DOI: https://doi.org/10.4143/crt.2024.706    [Accepted]
AbstractAbstract PDF
Purpose
Identifying the palliative care needs of patients with advanced cancer is important for maintaining quality of life and timely transition to palliative care. We aimed to validate the Korean Sheffield Profile for Assessment and Referral for Care (K-SPARC) in such patients and establish its psychometric properties, including reliability, validity, and responsiveness to change.
Materials and Methods
We used the forward-back translated version of SPARC, which was verified through a pilot study, to assess the palliative care needs of patients with advanced cancer. Reliability was evaluated by internal consistency using Cronbach's alpha coefficients and test-retest reliability. Criterion validity was analyzed against other questionnaires, including the Korean versions of the Functional Assessment of Cancer Therapy-General (FACT-G Korean) and Korean versions of the Edmonton Symptom Assessment System (K-ESAS). Factor analysis was used to assess construct validity.
Results
Two hundred fifty-nine patients were included from 2019 to 2022. Forty-nine percent of all patients were women, and the median age was 63 years. Cronbach’s alpha coefficient (range, 0.642–0.903) and test-retest reliability (range, 0.574–0.749) indicated acceptable reliability. The correlation coefficients between K-SPARC and FACT-G Korean suggested significant criterion validity. The correlation coefficients for the physical, social, emotional, and functional domains were 0.701, 0.249, 0.718, and 0.511, respectively (p-value <0.001, all). Factor analysis demonstrated satisfactory construct validity of the tool.
Conclusion
This study demonstrated the utility of K-SPARC as an evaluation tool for providing palliative care to patients with advanced cancer through psychometric validation; the tool had good internal consistency, reliability, and acceptable validity.
  • 354 View
  • 17 Download
Close layer
Palliative medicine
Factors Affecting Life-Sustaining Treatment Decisions and Changes in Clinical Practice after Enforcement of the Life-Sustaining Treatment (LST) Decision Act: A Tertiary Hospital Experience in Korea
Yoon Jung Jang, Yun Jung Yang, Hoi Jung Koo, Hye Won Yoon, Seongbeom Uhm, Sun Young Kim, Jeong Eun Kim, Jin Won Huh, Tae Won Kim, Seyoung Seo
Cancer Res Treat. 2025;57(1):280-288.   Published online July 1, 2024
DOI: https://doi.org/10.4143/crt.2024.360
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
In Korea, the Act on Hospice and Palliative Care and Decisions on Life-Sustaining Treatment (LST) was implemented on February 4, 2018. We aimed to investigate relevant factors and clinical changes associated with LST decisions after law enforcement.
Materials and Methods
This single-center retrospective study included patients who completed LST documents using legal forms at Asan Medical Center from February 5, 2018, to June 30, 2020.
Results
5,896 patients completed LST documents, of which 2,704 (45.8%) signed the documents in person, while family members of 3,192 (54%) wrote the documents on behalf of the patients. Comparing first year and following year of implementation of the act, the self-documentation rate increased (43.9% to 47.2%, p=0.014). Moreover, the number of LST decisions made during or after intensive care unit admission decreased (37.8% vs. 35.2%, p=0.045), and the completion rate of LST documents during chemotherapy increased (6.6% vs. 8.9%, p=0.001). In multivariate analysis, age < 65 (odds ratio [OR], 1.724; 95% confidence interval [CI], 1.538 to 1.933; p < 0.001), unmarried status (OR, 1.309; 95% CI, 1.097 to 1.561; p=0.003), palliative care consultation (OR, 1.538; 95% CI, 1.340 to 1.765; p < 0.001), malignancy (OR, 1.864; 95% CI, 1.628 to 2.133; p < 0.001), and changes in timing on the first year versus following year (OR, 1.124; 95% CI, 1.003 to 1.260; p=0.045) were related to a higher self-documentation rate.
Conclusion
Age < 65 years, unmarried status, malignancy, and referral to a palliative care team were associated with patients making LST decisions themselves. Furthermore, the subject and timing of LST decisions have changed with the LST act.
  • 1,064 View
  • 64 Download
Close layer
Development of a Prediction Model for Delirium in Hospitalized Patients with Advanced Cancer
Eun Hee Jung, Shin Hye Yoo, Si Won Lee, Beodeul Kang, Yu Jung Kim
Cancer Res Treat. 2024;56(4):1277-1287.   Published online February 26, 2024
DOI: https://doi.org/10.4143/crt.2023.1243
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Delirium is a common neurocognitive disorder in patients with advanced cancer and is associated with poor clinical outcomes. As a potentially reversible phenomenon, early recognition of delirium by identifying the risk factors demands attention. We aimed to develop a model to predict the occurrence of delirium in hospitalized patients with advanced cancer.
Materials and Methods
This retrospective study included patients with advanced cancer admitted to the oncology ward of four tertiary cancer centers in Korea for supportive cares and excluded those discharged due to death. The primary endpoint was occurrence of delirium. Sociodemographic characteristics, clinical characteristics, laboratory findings, and concomitant medication were investigated for associating variables. The predictive model developed using multivariate logistic regression was internally validated by bootstrapping.
Results
From January 2019 to December 2020, 2,152 patients were enrolled. The median age of patients was 64 years, and 58.4% were male. A total of 127 patients (5.9%) developed delirium during hospitalization. In multivariate logistic regression, age, body mass index, hearing impairment, previous delirium history, length of hospitalization, chemotherapy during hospitalization, blood urea nitrogen and calcium levels, and concomitant antidepressant use were significantly associated with the occurrence of delirium. The predictive model combining all four categorized variables showed the best performance among the developed models (area under the curve 0.831, sensitivity 80.3%, and specificity 72.0%). The calibration plot showed optimal agreement between predicted and actual probabilities through internal validation of the final model.
Conclusion
We proposed a successful predictive model for the risk of delirium in hospitalized patients with advanced cancer.

Citations

Citations to this article as recorded by  
  • Association Between Blood Urea Nitrogen and Delirium in Critically Ill Elderly Patients Without Kidney Diseases: A Retrospective Study and Mendelian Randomization Analysis
    Yipeng Fang, Xiaohong Tang, Ying Gao, Hui Xie, Yuehao Shen, Min Peng, Jie Liu, Yunfei Zhang, Yan Cui, Keliang Xie
    CNS Neuroscience & Therapeutics.2025;[Epub]     CrossRef
  • 1,558 View
  • 113 Download
  • 1 Web of Science
  • 1 Crossref
Close layer
Special Articles
Management of Physical Symptoms in Patients with Advanced Cancer during the Last Weeks and Days of Life
Ahsan Azhar, David Hui
Cancer Res Treat. 2022;54(3):661-670.   Published online June 30, 2022
DOI: https://doi.org/10.4143/crt.2022.143
AbstractAbstract PDFPubReaderePub
Patients with advanced cancer are faced with many devastating symptoms in the last weeks and days of life, such as pain, delirium, dyspnea, bronchial hypersecretions (death rattle) and intractable seizures. Symptom management in the last weeks of life can be particularly challenging because of the high prevalence of delirium complicating symptom assessment, high symptom expression secondary to psychosocial and spiritual factors, limited life-expectancy requiring special considerations for prognosis-based decision-making, and distressed caregivers. There is a paucity of research involving patients in the last weeks of life, contributing to substantial variations in clinical practice. In this narrative review, we shall review the existing literature and provide a practical approach to in-patient management of several of the most distressing physical symptoms in the last weeks to days of life.

Citations

Citations to this article as recorded by  
  • Comparing the use of aggressive end-of life care among frail and non-frail patients with cancer using a claims-based frailty index
    Rishi Sachdev, Galen Shearn-Nance, Long Vu, Wyatt P. Bensken, Sara L. Douglas, Siran M. Koroukian, Johnie Rose
    Journal of Geriatric Oncology.2024; 15(2): 101706.     CrossRef
  • 6,580 View
  • 178 Download
  • 1 Web of Science
  • 1 Crossref
Close layer
Psychological Aspects of Care in Cancer Patients in the Last Weeks/Days of Life
Sujin Ann-Yi, Eduardo Bruera
Cancer Res Treat. 2022;54(3):651-660.   Published online June 28, 2022
DOI: https://doi.org/10.4143/crt.2022.116
AbstractAbstract PDFPubReaderePub
Palliative care is comprised of an interdisciplinary team (IDT) approach with members from different disciplines who collaboratively work together to reduce multidimensional components of pain and suffering and improve quality of life for patients coping with a terminal illness. Psychosocial team members are integral to the palliative care IDT and provide expertise in assessment and empirically validated interventions to address psychological distress. The following paper will provide a review of different facets of psychological distress experienced by advanced cancer patients such as psychological disorders, existential distress, spiritual distress, caregiver distress, parental distress, and grief. Finally, an overview of commonly used screening and assessment tools as well as psychological interventions relevant for the palliative care population is presented.

Citations

Citations to this article as recorded by  
  • The Experience of Reflexive Hospice Care for Patients With Advanced Cancer: A Qualitative Study
    Xi Zhang, Tieying Zeng, Ye Chen
    Journal of Clinical Nursing.2025; 34(1): 247.     CrossRef
  • Psychosocial Distress Screening Among Interprofessional Palliative Care Teams: A Narrative Review
    Chelsea K. Brown, Cara L. Wallace
    Journal of Social Work in End-of-Life & Palliative Care.2024; 20(2): 161.     CrossRef
  • Diagnostic and therapeutic strategies in pancreatic adenosquamous carcinoma: Molecular and clinical insights in managing metastatic disease
    Nathaniel Grabill, Mena Louis, Mariah Cawthon, Claudia Gherasim, James Chambers
    Radiology Case Reports.2024; 19(12): 6016.     CrossRef
  • Enfoque global en la atención al final de vida. Aspectos médico-legales, éticos, sociales, psicológicos y de cuidados
    Josep Arimany-Manso, Francesc Torralba, Ana Isabel Lima, María Die Trill
    Medicina Clínica.2024;[Epub]     CrossRef
  • Perceived Shame and Stigma, and Other Psychosocial Predictors of Psychological Distress Among Cancer Patients in Malaysia
    Hui Ting Eyu, Nik Ruzyanei Nik Jaafar, Mohammad Farris Iman Leong Abdullah, Hajar Mohd Salleh Salimi, Mohd Razif Mohamad Yunus, Fuad Ismail, Nur Fa'izah Ab Muin, Noor Syazwani Abdul Aziz
    Psycho-Oncology.2024;[Epub]     CrossRef
  • Acceptance and Commitment Therapy (ACT) for people with advanced progressive illness, their caregivers and staff involved in their care: A scoping review
    Tilly Gibson Watt, David Gillanders, Juliet A Spiller, Anne M Finucane
    Palliative Medicine.2023; 37(8): 1100.     CrossRef
  • Palliative care competence among medical students
    Úrsula Bueno do Prado Guirro, Carla Corradi Perini, Luís Otávio Zatorre Fileno, Gustavo Belam Fioravanti, José Eduardo de Siqueira
    Revista Bioética.2023;[Epub]     CrossRef
  • Competencias en cuidados paliativos entre los estudiantes de medicina
    Úrsula Bueno do Prado Guirro, Carla Corradi Perini, Luís Otávio Zatorre Fileno, Gustavo Belam Fioravanti, José Eduardo de Siqueira
    Revista Bioética.2023;[Epub]     CrossRef
  • Competências em cuidados paliativos entre estudantes do curso de medicina
    Úrsula Bueno do Prado Guirro, Carla Corradi Perini, Luís Otávio Zatorre Fileno, Gustavo Belam Fioravanti, José Eduardo de Siqueira
    Revista Bioética.2023;[Epub]     CrossRef
  • 9,320 View
  • 251 Download
  • 5 Web of Science
  • 9 Crossref
Close layer
Palliative Sedation in End-of-Life Patients in Eastern Asia: A Narrative Review
Seung Hun Lee, Jung Hye Kwon, Young-Woong Won, Jung Hun Kang
Cancer Res Treat. 2022;54(3):644-650.   Published online April 19, 2022
DOI: https://doi.org/10.4143/crt.2022.187
AbstractAbstract PDFPubReaderePub
Although palliative sedation (PS) is a common practice in the palliative care of cancer patients in Western countries, there is little related research on the practice in Korea. PS can be classified into several categories according to sedation level and continuity. PS is clearly distinct from euthanasia. While euthanasia is illegal and regarded as unethical in Korea, there is little ethical and legal controversy about PS in terms of the doctrine of double effect. Most studies have asserted that PS does not shorten the survival of terminal cancer patients. Since preference for PS heavily depends on stakeholder value, it should be preceded by shared decision-making through full communication among the patient, family members, and medical team. This is a narrative review article analyzing previous studies, especially from the three Eastern Asian countries, Korea, Japan and Taiwan, which share similar cultures compared with Western countries. Practical issues concerning PS—for example, prevalence, type and dosage of medications, salvage medication, timing of its initiation, and assessment—are described in detail.

Citations

Citations to this article as recorded by  
  • Continuous Sedation in Palliative Care in Portugal: A Prospective Multicentric Study
    José António Ferraz-Gonçalves, Alice Flores, Ana Abreu Silva, Ana Simões, Carmen Pais, Clarisse Melo, Diana Pirra, Dora Coelho, Lília Conde, Lorena Real, Madalena Feio, Manuel Barbosa, Maria de Lurdes Martins, Marlene Areias, Rafael Muñoz-Romero, Rita Cun
    Journal of Palliative Care.2025; 40(1): 72.     CrossRef
  • Ethical and moral principles for oncology healthcare workers: A brief report from a Bioethics consortium emphasizing on need for education
    Manjeshwar S. Baliga, Vijaya Marakala, Lal P. Madathil, Thomas George, Russell F. D’souza, Princy L. Palatty
    Journal of Education and Health Promotion.2024;[Epub]     CrossRef
  • Survival Outcomes in Palliative Sedation Based on Referring Versus On-Call Physician Prescription
    Cristina Lojo-Cruz, Juan Mora-Delgado, Víctor Rivas Jiménez, Fernando Carmona Espinazo, Juan-Bosco López-Sáez
    Journal of Clinical Medicine.2023; 12(16): 5187.     CrossRef
  • Current Status and Future Directions of Research on Palliative Sedation
    In Cheol Hwang
    The Korean Journal of Hospice and Palliative Care.2022; 25(4): 193.     CrossRef
  • Legislation concerning Physician-assisted Suicide in Korea
    Younsuck KOH
    Korean Journal of Medical Ethics.2022; 25(4): 313.     CrossRef
  • 5,982 View
  • 177 Download
  • 4 Web of Science
  • 5 Crossref
Close layer
Original Article
Palliative medicine
A Prognostic Model to Facilitate Palliative Care Referral in Oncology Outpatients
Yu Jung Kim, Yusuke Hiratsuka, Sang-Yeon Suh, Beodeul Kang, Si Won Lee, Hong-Yup Ahn, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Keun-Wook Lee, Jee Hyun Kim, Jong Seok Lee
Cancer Res Treat. 2022;54(2):621-629.   Published online July 12, 2021
DOI: https://doi.org/10.4143/crt.2021.483
AbstractAbstract PDFPubReaderePub
Purpose
We aimed to develop a prognostic model to assist palliative care referral at least 3 months before death in advanced cancer patients treated at an outpatient medical oncology clinic.
Materials and Methods
In this prospective cohort study, a total of 200 patients were enrolled at a tertiary cancer center in South Korea. The major eligibility criterion was an expected survival of less than a year as estimated by their oncologists. We analyzed the influences of known prognostic factors along with chemotherapy status, mid-arm circumference, and triceps skinfold thickness on survival time.
Results
The mean age of the patients was 64.5 years, 36% were female, and the median survival time was 7.6 months. In the multivariate analysis, we found 6 significant factors related to poor survival: a poor Eastern Cooperative Oncology Group (ECOG) performance status (≥2), not undergoing chemotherapy, anorexia, a low lymphocyte level (<12%), a high lactate dehydrogenase (LDH) level (≥300 IU/L), and a low mid-arm circumference (<23 cm). We developed a prognostic model (score, 0-8.0) to predict 3-month survival based on the multivariate analysis. Patients who scored ≥4.0 points had a short survival of less than 3 months (p<0.001). The discriminating ability of the prognostic model using the area under the receiver operating characteristic curve (AUC) was 0.88.
Conclusion
The prognostic model using ECOG performance status, chemotherapy status, anorexia, lymphocytes, LDH, and mid-arm circumference can predict 3-month survival in medical oncology outpatients. It can alert oncologists to refer patients to palliative care specialists before it is too late.

Citations

Citations to this article as recorded by  
  • Clinicians’ Prediction of Survival Is Most Useful for Palliative Care Referral
    Eun Hee Jung, Yusuke Hiratsuka, Sang-Yeon Suh, Seok-Joon Yoon, Beodeul Kang, Si Won Lee, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Keun-Wook Lee, Yu Jung Kim
    Palliative Medicine Reports.2024; 5(1): 365.     CrossRef
  • 7,915 View
  • 168 Download
  • 3 Web of Science
  • 1 Crossref
Close layer
Special Article
Current Status and Cardinal Features of Patient Autonomy after Enactment of the Life-Sustaining Treatment Decisions Act in Korea
Hwa Jung Kim, Yu Jung Kim, Jung Hye Kwon, Young-Woong Won, Ha Yeon Lee, Sun Kyung Baek, Hyewon Ryu, Do Yeun Kim
Cancer Res Treat. 2021;53(4):917-925.   Published online June 2, 2021
DOI: https://doi.org/10.4143/crt.2021.324
AbstractAbstract PDFPubReaderePub
Purpose
The main purpose of the Life-Sustaining Treatment Decisions Act recently enacted in Korea is to respect the patient’s self-determination. We aimed to investigate the current status and features of patient self-determination after implementation of the law.
Materials and Methods
Between February 2018 and January 2019, 54,635 cancer deaths were identified from the National Health Insurance Service (NHIS) database. We analyzed the characteristics of decedents who complied with the law process by self-determination compared with decedents with family determination and with decedents who did not comply with the law process.
Results
In multivariable analysis, patients with self-determination were younger, were less likely to live in rural areas, were less likely to belong to the highest income quintile, were less likely to be treated in general hospitals, and were more likely to show a longer time from cancer diagnosis compared with patients with family determination. Compared with patients who did not comply with the law process, patients with self-determination were younger, lived in Seoul or capital area, were less likely to belong to the highest income quintile, were treated in general hospitals, were less likely to have genitourinary or hematologic malignancies, scored higher on the Charlson comorbidity index, and showed a longer time from cancer diagnosis. Patients with self-determination were more likely to use hospice and less likely to use intensive care units (ICUs) at the end-of-life (EOL).
Conclusion
Decedents with self-determination were more likely to be younger, reside in the Seoul or capital area, show a longer time from cancer diagnosis, and were less likely to belong to the highest income quintile. They utilized hospice more frequently, and received less ICU care at the EOL.

Citations

Citations to this article as recorded by  
  • The effects of hospice care on healthcare expenditure among cancer patients
    Hoyol Jhang, Wonjeong Jeong, Hyun-Soo Zhang, Dong-Woo Choi, Hyejung Kang, Sohee Park
    BMC Health Services Research.2023;[Epub]     CrossRef
  • Problems Related to the Act on Decisions on Life-Sustaining Treatment and Directions for Improvement
    Dae Seog Heo, Shin Hye Yoo, Bhumsuk Keam, Sang Ho Yoo, Younsuck Koh
    The Korean Journal of Hospice and Palliative Care.2022; 25(1): 1.     CrossRef
  • Aggressiveness of care in the last days of life in the emergency department of a tertiary hospital in Korea
    Jung Sun Kim, Sun Young Lee, Min Sung Lee, Shin Hye Yoo, Jeongmi Shin, Wonho Choi, Yejin Kim, Hyung Sook Han, Jinui Hong, Bhumsuk Keam, Dae Seog Heo
    BMC Palliative Care.2022;[Epub]     CrossRef
  • Use of antimicrobial agents in actively dying inpatients after suspension of life-sustaining treatments: Suggestion for antimicrobial stewardship
    Dayeong Kim, Subin Kim, Kyoung Hwa Lee, Sang Hoon Han
    Journal of Microbiology, Immunology and Infection.2022; 55(4): 651.     CrossRef
  • Association of perceived life satisfaction with attitudes toward life-sustaining treatment among the elderly in South Korea: a cross-sectional study
    Il Yun, Hyunkyu Kim, Eun-Cheol Park, Suk-Yong Jang
    BMC Palliative Care.2022;[Epub]     CrossRef
  • The Law Changes Behaviors: Is It Just Enough?
    Dae Ho Lee
    Cancer Research and Treatment.2021; 53(4): 895.     CrossRef
  • 6,212 View
  • 133 Download
  • 4 Web of Science
  • 6 Crossref
Close layer
Original Articles
Palliative Medicine
Safety, Efficacy, and Patient Satisfaction with Initial Peripherally Inserted Central Catheters Compared with Usual Intravenous Access in Terminally Ill Cancer Patients: A Randomized Phase II Study
Eun Ju Park, Kwonoh Park, Jae-Joon Kim, Sang-Bo Oh, Ki Sun Jung, So Yeon Oh, Yun Jeong Hong, Jin Hyeok Kim, Joo Yeon Jang, Ung-Bae Jeon
Cancer Res Treat. 2021;53(3):881-888.   Published online December 22, 2020
DOI: https://doi.org/10.4143/crt.2020.1008
AbstractAbstract PDFPubReaderePub
Purpose
The purpose of this study was to investigate whether routine insertion of peripherally inserted central catheter (PICC) at admission to a hospice-palliative care (HPC) unit is acceptable in terms of safety and efficacy and whether it results in superior patient satisfaction compared to usual intravenous (IV) access.
Materials and Methods
Terminally ill cancer patients were randomly assigned to two arms: routine PICC access and usual IV access arm. The primary endpoint was IV maintenance success rate, defined as the rate of functional IV maintenance until the intended time (discharge, transfer, or death).
Results
A total of 66 terminally ill cancer patients were enrolled and randomized to study arms. Among them, 57 patients (routine PICC, 29; usual IV, 28) were analyzed. In the routine PICC arm, mean time to PICC was 0.84 days (range, 0 to 3 days), 27 patients maintained PICC with function until the intended time. In the usual IV arm, 11 patients maintained peripheral IV access until the intended time, and 15 patients underwent PICC insertion. The IV maintenance success rate in the routine PICC arm (27/29, 93.1%) was similar to that in the usual IV arm (26/28, 92.8%, p=0.958). Patient satisfaction at day 5 was better in the routine PICC arm (97%, ‘a little comfort’ or ‘much comfort’) compared with the usual IV arm (21%) (p <0.001).
Conclusion
Routine PICC insertion in terminally ill cancer patients was comparable in safety and efficacy and resulted in superior satisfaction compared with usual IV access. Thus, routine PICC insertion could be considered at admission to the HPC unit.

Citations

Citations to this article as recorded by  
  • Implementation of Tunneled Peripherally Inserted Central Catheters Placement in Cancer Patients: A Randomized Multicenter Study
    Yuan Sheng, Li-Hong Yang, Yan Wu, Wei Gao, Sheng-Yi Dongye
    Clinical Nursing Research.2024; 33(1): 19.     CrossRef
  • The Use of a High Flow PICC Catheter for Stem Cell and Lymphocyte Apheresis: The Initial Experience of a Pediatric Oncology Center in Brazil
    Vilani Kremer, Andréia Rheinheimer, Ana Luiza Rodrigues, Andressa Taborda, Robson Coelho, Antonella Zanette
    Journal of Pediatric Surgery.2024; 59(8): 1600.     CrossRef
  • Analysis of Risk Factors for Peripherally Inserted Central Venous Catheter-Associated Bloodstream Infection
    Sungho Lee, Kwanhoon Park, Kang Yoon Lee, Dongbeen Choi, Ji Young Jang
    Journal of Acute Care Surgery.2024; 14(1): 9.     CrossRef
  • Central venous access device terminologies, complications, and reason for removal in oncology: a scoping review
    Kerrie Curtis, Karla Gough, Meinir Krishnasamy, Elena Tarasenko, Geoff Hill, Samantha Keogh
    BMC Cancer.2024;[Epub]     CrossRef
  • A Phase II Study About Efficacy and Safety of the Continuous IntraVenous Infusion of Ketamine as Adjuvant to Opioids in Terminally Ill Cancer Patients With Refractory Cancer Pain (CIVIK Trial)
    Kwonoh Park, Jae-Joon Kim, Sang-Bo Oh, So Yeon Oh, Yun Jeong Hong, Seo-jun Kim, Eun-Ju Park, Nayeon Choi, Seon-Hi Shin, Sungeun Kim, Heejung Ko
    American Journal of Hospice and Palliative Medicine®.2024;[Epub]     CrossRef
  • Use of peripherally inserted central venous catheters and midline catheters for palliative care in patients with cancer: a systematic review
    Eva Gravdahl, Dagny Faksvåg Haugen, Olav Magnus Fredheim
    Supportive Care in Cancer.2024;[Epub]     CrossRef
  • Machine Learning Predicts Peripherally Inserted Central Catheters-Related Deep Vein Thrombosis Using Patient Features and Catheterization Technology Features
    Yuan Sheng, Wei Gao
    Clinical Nursing Research.2024; 33(6): 460.     CrossRef
  • Safety of Cryopreserved Stem Cell Infusion through a Peripherally Inserted Central Venous Catheter
    Sławomir Milczarek, Piotr Kulig, Alina Zuchmańska, Bartłomiej Baumert, Bogumiła Osękowska, Anna Bielikowicz, Ewa Wilk-Milczarek, Bogusław Machaliński
    Cancers.2023; 15(4): 1338.     CrossRef
  • Use and safety of peripherally inserted central catheters and midline catheters in palliative care cancer patients: a retrospective review
    Eva Gravdahl, Siri Steine, Knut Magne Augestad, Olav Magnus Fredheim
    Supportive Care in Cancer.2023;[Epub]     CrossRef
  • Complications of Central Venous Access Devices Used in Palliative Care Settings for Terminally Ill Cancer Patients: A Systematic Review and Meta-Analysis
    Clement Chun-Him Wong, Horace Cheuk-Wai Choi, Victor Ho-Fun Lee
    Cancers.2023; 15(19): 4712.     CrossRef
  • Safety and Efficacy of Peripherally Inserted Central Catheter Placement by Surgical Intensivist–Led Vascular Access Team
    Byunghyuk Yu, Jihoon Hong
    Vascular Specialist International.2022;[Epub]     CrossRef
  • Effects of parenteral nutrition and hydration on survival in advanced cancer patients with malignant bowel obstruction: secondary analysis of a multicenter prospective cohort study
    Sayaka Arakawa, Koji Amano, Shunsuke Oyamada, Isseki Maeda, Hiroto Ishiki, Tomofumi Miura, Yutaka Hatano, Akemi Shirado Naito, Mamiko Sato, Tetsuya Ito, Kazuhiro Kosugi, Satoshi Miyake, Tatsuya Morita, Masanori Mori, Satoshi Inoue, Naosuke Yokomichi, Keng
    Supportive Care in Cancer.2021; 29(12): 7541.     CrossRef
  • Catheter-related bloodstream infection associated with multiple insertions of the peripherally inserted central catheter in patients with hematological disorders
    Yoshinori Hashimoto, Rina Hosoda, Hiromi Omura, Takayuki Tanaka
    Scientific Reports.2021;[Epub]     CrossRef
  • 6,518 View
  • 200 Download
  • 13 Crossref
Close layer
Palliative medicine
A National Study of Life-Sustaining Treatments in South Korea: What Factors Affect Decision-Making?
So-Youn Park, Bomyee Lee, Jeong Yeon Seon, In-Hwan Oh
Cancer Res Treat. 2021;53(2):593-600.   Published online November 21, 2020
DOI: https://doi.org/10.4143/crt.2020.803
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
This cross-sectional study investigated the status of life-sustaining treatment (LST) practices and identified characteristics and factors influencing decision-making practices.
Materials and Methods
The National Agency for Management of Life-sustaining Treatment retains records provided by doctors regarding patients subject to LST implementation. A total of 71,327 patients receiving LST were identified. We analyzed all nationally reported data between February 2018 and October 2019. Indicators such as the proportion of deaths, records for decision to terminate LST, implementation of LST records, and registration of Advance Statements on LST were analyzed.
Results
A total of 67,252 (94.3%) end-of life decisions were implemented in South Korea. The proportion of deaths preceded by a LST plan, non-self-determination LST decision, and any advance statements was 33.5% (23,891/71,327), 66.5% (47,436/71,327), and 1.2% (890/71,327), respectively. The logistic regression model revealed that self-determination to terminate LST was more frequent for men than for women and higher for those aged 30-69. Disability (odds ratio [OR], 0.59; 95% confidence interval [CI], 0.56 to 0.61), living in non-metropolitan areas (OR, 0.84; 95% CI, 0.81 to 0.86), and disease comorbidity was independently associated with a low level of self-determination.
Conclusion
After the implementation of the new LST Act, about a third of patients in end-of-life process made decisions regarding their medical LST. However, family members still play a major role in LST decisions where the patient’s intention cannot be verified. Decisions related to LST are predominantly made when death is imminent. Thus, it is necessary to increase awareness of end-of-life LST decision-making among medical staff and the public.

Citations

Citations to this article as recorded by  
  • Factors Affecting Life-Sustaining Treatment Decisions and Changes in Clinical Practice after Enforcement of the Life-Sustaining Treatment (LST) Decision Act: A Tertiary Hospital Experience in Korea
    Yoon Jung Jang, Yun Jung Yang, Hoi Jung Koo, Hye Won Yoon, Seongbeom Uhm, Sun Young Kim, Jeong Eun Kim, Jin Won Huh, Tae Won Kim, Seyoung Seo
    Cancer Research and Treatment.2025; 57(1): 280.     CrossRef
  • Characteristics of Life-Sustaining Treatment Decisions: National Data Analysis in South Korea
    Jiyeon Choi, Heejung Jeon, Ilhak Lee
    Asian Bioethics Review.2024; 16(1): 33.     CrossRef
  • Recent Trends in the Withdrawal of Life-Sustaining Treatment in Patients with Acute Cerebrovascular Disease : 2017–2021
    Seung Hwan Kim, Ji Hwan Jang, Young Zoon Kim, Kyu Hong Kim, Taek Min Nam
    Journal of Korean Neurosurgical Society.2024; 67(1): 73.     CrossRef
  • The Impact of Withdrawing or Withholding of Life-Sustaining Treatment: A Nationwide Case-Control Study Based on Medical Cost Analysis
    Claire Junga Kim, Do-Kyong Kim, Sookyeong Mun, Minkook Son
    Journal of Korean Medical Science.2024;[Epub]     CrossRef
  • Characteristics and outcomes of patients with do-not-resuscitate and physician orders for life-sustaining treatment in a medical intensive care unit: a retrospective cohort study
    Song-I Lee, Ye-Rin Ju, Da Hyun Kang, Jeong Eun Lee
    BMC Palliative Care.2024;[Epub]     CrossRef
  • Clinical Characteristics and Prognosis of Older Patients with Coronavirus Disease 2019 Requiring Mechanical Ventilation
    Green Hong, Da Hyun Kang, Sunghoon Park, Su Hwan Lee, Onyu Park, Taehwa Kim, Hye Ju Yeo, Jin Ho Jang, Woo Hyun Cho, Song I Lee
    Journal of Personalized Medicine.2024; 14(6): 657.     CrossRef
  • Comparison of factors influencing the decision to withdraw life-sustaining treatment in intensive care unit patients after implementation of the Life-Sustaining Treatment Act in Korea
    Claire Junga Kim, Kyung Sook Hong, Sooyoung Cho, Jin Park
    Acute and Critical Care.2024; 39(2): 294.     CrossRef
  • Validation of the Korean Version of the Clinical Frailty Scale-Adjusted Korean Triage and Acuity Scale for Older Patients in the Emergency Department
    Ho Sub Chung, Yunhyung Choi, Ji Yeon Lim, Keon Kim, Sung Jin Bae, Yoon Hee Choi, Dong Hoon Lee
    Medicina.2024; 60(6): 955.     CrossRef
  • Psychosocial Factors Associated With Thoughts Regarding Life-Sustaining Treatment for Oneself and Family Members
    Jeewon Lee, Shin-Gyeom Kim, Soyoung Irene Lee, HyunChul Youn
    Psychiatry Investigation.2024; 21(6): 646.     CrossRef
  • Emergency department and intensive care unit health professionals' knowledge and application of the law that applies to end-of-life decision-making for adults: A scoping review of the literature
    Jayne Hewitt, Nemat Alsaba, Katya May, Halima Sadia Noon, Cooper Rennie, Andrea P. Marshall
    Australian Critical Care.2023; 36(4): 628.     CrossRef
  • Decision and Practice of End-of-Life Care in Lung Disease Patients with Physicians Orders for Life Sustaining Treatment
    Yu Mi Oh, Yoon Na Kang, Soo Jung Han, Jeong Hye Kim
    The Korean Journal of Hospice and Palliative Care.2023; 26(1): 7.     CrossRef
  • Advance Care Planning in South Korea
    Yu Jung Kim, Sun-Hyun Kim
    Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen.2023; 180: 68.     CrossRef
  • Participation and Influencing Factors in the Decision-Making of Life-Sustaining Treatment: A Focus on Deceased Patients with Hematologic Neoplasms
    Jae Eun Jang, Jeong Moon Ryu, Min Hee Heo, Do Eun Kwon, Ji Yeon Seo, Dong Yeon Kim
    The Korean Journal of Hospice and Palliative Care.2023; 26(2): 69.     CrossRef
  • Comparison of the end-of-life decisions of patients with hospital-acquired pneumonia after the enforcement of the life-sustaining treatment decision act in Korea
    Ae-Rin Baek, Sang-Bum Hong, Soohyun Bae, Hye Kyeong Park, Changhwan Kim, Hyun-Kyung Lee, Woo Hyun Cho, Jin Hyoung Kim, Youjin Chang, Heung Bum Lee, Hyun-Il Gil, Beomsu Shin, Kwang Ha Yoo, Jae Young Moon, Jee Youn Oh, Kyung Hoon Min, Kyeongman Jeon, Moon S
    BMC Medical Ethics.2023;[Epub]     CrossRef
  • Analysis of Cancer Patient Decision-Making and Health Service Utilization after Enforcement of the Life-Sustaining Treatment Decision-Making Act in Korea
    Dalyong Kim, Shin Hye Yoo, Seyoung Seo, Hyun Jung Lee, Min Sun Kim, Sung Joon Shin, Chi-Yeon Lim, Do Yeun Kim, Dae Seog Heo, Chae-Man Lim
    Cancer Research and Treatment.2022; 54(1): 20.     CrossRef
  • Problems Related to the Act on Decisions on Life-Sustaining Treatment and Directions for Improvement
    Dae Seog Heo, Shin Hye Yoo, Bhumsuk Keam, Sang Ho Yoo, Younsuck Koh
    The Korean Journal of Hospice and Palliative Care.2022; 25(1): 1.     CrossRef
  • Derivation and performance of an end-of-life practice score aimed at interpreting worldwide treatment-limiting decisions in the critically ill
    Spyros D. Mentzelopoulos, Su Chen, Joseph L. Nates, Jacqueline M. Kruser, Christiane Hartog, Andrej Michalsen, Nikolaos Efstathiou, Gavin M. Joynt, Suzana Lobo, Alexander Avidan, Charles L. Sprung, Wesley Ely, Erwin J. O. Kompanje, Mervyn Mer, Charles Fel
    Critical Care.2022;[Epub]     CrossRef
  • Will implementation of the Life-sustaining Treatment Decisions Act reduce the incidence of cardiopulmonary resuscitation?
    In-Ae Song
    Acute and Critical Care.2022; 37(2): 256.     CrossRef
  • The cascade of care for latent tuberculosis infection in congregate settings: A national cohort analysis, Korea, 2017–2018
    Jinsoo Min, Hyung Woo Kim, Helen R. Stagg, Molebogeng X. Rangaka, Marc Lipman, Ibrahim Abubakar, Yunhee Lee, Jun-Pyo Myong, Hyunsuk Jeong, Sanghyuk Bae, Ah Young Shin, Ji Young Kang, Sung-Soon Lee, Jae Seuk Park, Hyeon Woo Yim, Ju Sang Kim
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Preparation and Practice of the Necessary Documents in Hospital for the “Act on Decision of Life-Sustaining Treatment for Patients at the End-of-Life”
    Sun Kyung Baek, Hwa Jung Kim, Jung Hye Kwon, Ha Yeon Lee, Young-Woong Won, Yu Jung Kim, Sujin Baik, Hyewon Ryu
    Cancer Research and Treatment.2021; 53(4): 926.     CrossRef
  • 6,982 View
  • 183 Download
  • 17 Web of Science
  • 20 Crossref
Close layer
General
Pilot study for the Psychometric Validation of the Sheffield Profile for Assessment and Referral to Care (SPARC) in Korean Cancer Patients
Jung Hye Kwon, Sun Kyung Baek, Do Yeun Kim, Yu Jung Kim, Myung Ah Lee, Hye Jin Choi, Ja Min Byun, Jin Young Jeong, Sam H Ahmedzai, Geun-Doo Jang
Cancer Res Treat. 2021;53(1):25-31.   Published online August 31, 2020
DOI: https://doi.org/10.4143/crt.2020.235
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
This study aimed to validate the Sheffield Profile for Assessment and Referral to Care (SPARC) as an effective tool for screening palliative care needs among Korean cancer patients.
Materials and Methods
The English version of the SPARC was translated by four Korean oncologists and reconciled by a Korean language specialist and a medical oncologist fluent in English. After the first version of the Korean SPARC (K-SPARC) was developed, back-translation into English was performed by a professional translator and bilingual oncologist. The back-translated version was reviewed by the original author (S.H.A.), and modifications were made (ver. 2). The second version of the K-SPARC was tested against other questionnaires, including the Functional Assessment of Cancer Therapy-General (FACT-G) and the Edmonton Symptom Assessment System (ESAS).
Results
Thirty patients were enrolled in the pilot trial. Fifteen were male, and the median age was 64.5 years. Six patients had an Eastern Cooperative Oncology Group performance status of 2 or more. All patients except one were receiving chemotherapy. Regarding internal consistency, the Cronbach’s α scores for physical symptoms, psychological issues, religious and spiritual issues, independency and activity, family and social issues, and treatment issues were 0.812, 0.804, 0.589, 0.843, 0.754, and 0.822, respectively. The correlation coefficients between the SPARC and FACT-G were 0.479 (p=0.007) for the physical domain and –0.130 (p=0.493) for the social domain.
Conclusion
This pilot study indicates that the K-SPARC could be a reliable tool to screen for palliative care needs among Korean cancer patients. A further study to validate our findings is ongoing.

Citations

Citations to this article as recorded by  
  • Translation and linguistic validation of the Sheffield Profile for Assessment and Referral for Care (SPARC) to Colombian Spanish
    Socorro Moreno, Cindy V. Mendieta, Esther de Vries, Sam H. Ahmedzai, Karen Rivera, Camilo Cortes-Mora, Jose A. Calvache
    Palliative and Supportive Care.2024; 22(6): 1801.     CrossRef
  • Validation of traditional Chinese version of Sheffield Profile for Assessment and Referral for Care Questionnaire in Taiwanese patients
    Ming-Chieh Tsai, Yun-Yun Chou, El-Wui Loh, Ashleigh Peng Lin, Hsueh-Chi Wu, Li-Sin Hsiao, Chia-Li Chang, Shu-Fen Chen, Sam H. Ahmedzai, Ka-Wai Tam
    Journal of the Chinese Medical Association.2024; 87(1): 58.     CrossRef
  • Validation of the Spanish translation Sheffield Profile for Assessment and Referral for Care (SPARC-Sp) at the Hospital Universitario San Jose of Popayan, Colombia
    Cindy V. Mendieta, Jose A. Calvache, Martín A. Rondón, Carlos Javier Rincón-Rodríguez, Sam H. Ahmedzai, Esther de Vries
    Palliative and Supportive Care.2024; 22(5): 1282.     CrossRef
  • Co-Designing a Strategy for Implementing the SPARC Holistic Needs Assessment Tool in the Colombian Clinical Context
    Cindy V. Mendieta, Esther de Vries, Jose Andrés Calvache, Sam H. Ahmedzai, Gillian Prue, Tracey McConnell, Joanne Reid
    Healthcare.2023; 11(22): 2917.     CrossRef
  • Outpatient palliative care referral system (PCRS) for patients with advanced cancer: an impact evaluation protocol
    Cinzia Brunelli, Ernesto Zecca, Alessandra Pigni, Paola Bracchi, Mariangela Caputo, Silvia Lo Dico, Viviana Fusetti, Antonino Tallarita, Cristiana Bergamini, Marta Brambilla, Alessandra Raimondi, Monica Niger, Salvatore Provenzano, Pierangela Sepe, Sara A
    BMJ Open.2022; 12(10): e059410.     CrossRef
  • Unmet needs related to the quality of life of advanced cancer patients in Korea: a qualitative study
    Jeehee Pyo, Minsu Ock, Mina Lee, Juhee Kim, Jaekyung Cheon, Juhee Cho, Jung Hye Kwon, Hyeyeoung Kim, Hyeon-Su Im, Young Joo Min, Su-Jin Koh
    BMC Palliative Care.2021;[Epub]     CrossRef
  • 7,831 View
  • 164 Download
  • 5 Web of Science
  • 6 Crossref
Close layer
Implication of the Life-Sustaining Treatment Decisions Act on End-of-Life Care for Korean Terminal Patients
Jung Sun Kim, Shin Hye Yoo, Wonho Choi, Yejin Kim, Jinui Hong, Min Sun Kim, Hye Yoon Park, Bhumsuk Keam, Dae Seog Heo
Cancer Res Treat. 2020;52(3):917-924.   Published online March 23, 2020
DOI: https://doi.org/10.4143/crt.2019.740
AbstractAbstract PDFPubReaderePub
Purpose
Life-sustaining treatment (LST) decisions for patients and caregivers at the end-of-life (EOL) process are supported by the “Act on Hospice and Palliative Care and Decisions on LST for Patients at the EOL,” enforced in February 2018. Itremains unclear whether the act changes EOL decisions and LST implementation in clinical practice. For this study, we investigated patients’ decision-making regarding LSTs during the EOL process since the act’s enforcement.
Materials and Methods
Retrospective reviews were conducted on adult patients who were able to decide to terminate LST and died at Seoul National University Hospital between February 5, 2018, and February 5, 2019. We examined demographics, who made the decisions, the type and date of documentation confirming patient's LST, and whether the LST was withheld or withdrawn.
Results
Of 809 patients who were enrolled, 29% (n=231) completed forms regarding LST themselves, and 71% (n=578) needed family members to decide. The median time from confirmation of the EOL process to death and from the Advance Statement to death were 2 and 5 days, respectively (both ranges, 0 to 244). In total, 90% (n=727) of patients withheld treatment, and 10% (n=82)withdrew it. We found a higher withdrawal rate when family members made the decisions (13.3% vs. 1.7%, p < 0.001).
Conclusion
After the act’s enforcement, withdrawing LSTs became lawful and self-determination rates increased. Family members still make 71% of decisions regarding LSTs, but these are often inconsistent with the patients’ wishes; thus, further efforts are needed to integrate the new act into clinical practice.

Citations

Citations to this article as recorded by  
  • Factors Affecting Life-Sustaining Treatment Decisions and Changes in Clinical Practice after Enforcement of the Life-Sustaining Treatment (LST) Decision Act: A Tertiary Hospital Experience in Korea
    Yoon Jung Jang, Yun Jung Yang, Hoi Jung Koo, Hye Won Yoon, Seongbeom Uhm, Sun Young Kim, Jeong Eun Kim, Jin Won Huh, Tae Won Kim, Seyoung Seo
    Cancer Research and Treatment.2025; 57(1): 280.     CrossRef
  • Development of Public Health Center‐Based Culturally Tailored Hypertension Self‐Care Intervention Among Adults in Rural Ghana
    Kennedy Diema Konlan, Hyeonkyeong Lee, Yeonsoo Jang, Seung Eun Lee, Soyoon Kim
    Public Health Nursing.2025;[Epub]     CrossRef
  • Recent Trends in the Withdrawal of Life-Sustaining Treatment in Patients with Acute Cerebrovascular Disease : 2017–2021
    Seung Hwan Kim, Ji Hwan Jang, Young Zoon Kim, Kyu Hong Kim, Taek Min Nam
    Journal of Korean Neurosurgical Society.2024; 67(1): 73.     CrossRef
  • Characteristics and outcomes of patients with do-not-resuscitate and physician orders for life-sustaining treatment in a medical intensive care unit: a retrospective cohort study
    Song-I Lee, Ye-Rin Ju, Da Hyun Kang, Jeong Eun Lee
    BMC Palliative Care.2024;[Epub]     CrossRef
  • Comparison of factors influencing the decision to withdraw life-sustaining treatment in intensive care unit patients after implementation of the Life-Sustaining Treatment Act in Korea
    Claire Junga Kim, Kyung Sook Hong, Sooyoung Cho, Jin Park
    Acute and Critical Care.2024; 39(2): 294.     CrossRef
  • End-of-life care in the intensive care unit: the optimal process of decision to withdrawing life-sustaining treatment based on the Korean medical environment and culture
    Ho Jin Yong, Dohhyung Kim
    Acute and Critical Care.2024; 39(2): 321.     CrossRef
  • Inpatient Hospice Care in Korea during the COVID-19 Pandemic: A Preliminary Study
    Youn Seon Choi, Sun Wook Hwang, In Cheol Hwang
    Journal of Hospice and Palliative Care.2024; 27(2): 82.     CrossRef
  • Issues and implications of the life-sustaining treatment decision act: comparing the data from the survey and clinical data of inpatients at the end-of-life process
    Eunjeong Song, Dongsoon Shin, Jooseon Lee, Seonyoung Yun, Minjeong Eom, Suhee Oh, Heejung Lee, Jiwan Lee, Rhayun Song
    BMC Medical Ethics.2024;[Epub]     CrossRef
  • Epidemiology of patients who died in the emergency departments and need of end-of-life care in Korea from 2016 to 2019
    Sun Young Lee, Young Sun Ro, Sang Do Shin, Eunsil Ko, Seong Jung Kim
    Scientific Reports.2023;[Epub]     CrossRef
  • Modification of termination of resuscitation rule with compression time interval in South Korea
    Song Yi Park, Daesung Lim, Ji Ho Ryu, Yong Hwan Kim, Byungho Choi, Sun Hyu Kim
    Scientific Reports.2023;[Epub]     CrossRef
  • Use of high‐flow nasal cannula oxygen therapy for patients with terminal cancer at the end of life
    Jung Sun Kim, Jeongmi Shin, Nam Hee Kim, Sun Young Lee, Shin Hye Yoo, Bhumsuk Keam, Dae Seog Heo
    Cancer Medicine.2023; 12(13): 14612.     CrossRef
  • Participation and Influencing Factors in the Decision-Making of Life-Sustaining Treatment: A Focus on Deceased Patients with Hematologic Neoplasms
    Jae Eun Jang, Jeong Moon Ryu, Min Hee Heo, Do Eun Kwon, Ji Yeon Seo, Dong Yeon Kim
    The Korean Journal of Hospice and Palliative Care.2023; 26(2): 69.     CrossRef
  • Advance Care Planning in South Korea
    Yu Jung Kim, Sun-Hyun Kim
    Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen.2023; 180: 68.     CrossRef
  • Preferred versus Actual Place of Care and Factors Associated with Home Discharge among Korean Patients with Advanced Cancer: A Retrospective Cohort Study
    In Young Hwang, Yohan Han, Min Sun Kim, Kyae Hyung Kim, Belong Cho, Wonho Choi, Yejin Kim, Shin Hye Yoo, Sun Young Lee
    Healthcare.2023; 11(13): 1939.     CrossRef
  • Patient and hospital characteristics associated with do-not-resuscitate/do-not-intubate orders: a cross-sectional study based on the Taiwan stroke registry
    Hsu-Ling Yeh, Fang-I Hsieh, Li-Ming Lien, Wen-Hua Kuo, Jiann-Shing Jeng, Yu Sun, Cheng-Yu Wei, Po-Yen Yeh, Hei-Tung Yip, Cheng-Li Lin, Nicole Huang, Kai-Cheng Hsu
    BMC Palliative Care.2023;[Epub]     CrossRef
  • Analysis of Cancer Patient Decision-Making and Health Service Utilization after Enforcement of the Life-Sustaining Treatment Decision-Making Act in Korea
    Dalyong Kim, Shin Hye Yoo, Seyoung Seo, Hyun Jung Lee, Min Sun Kim, Sung Joon Shin, Chi-Yeon Lim, Do Yeun Kim, Dae Seog Heo, Chae-Man Lim
    Cancer Research and Treatment.2022; 54(1): 20.     CrossRef
  • Problems Related to the Act on Decisions on Life-Sustaining Treatment and Directions for Improvement
    Dae Seog Heo, Shin Hye Yoo, Bhumsuk Keam, Sang Ho Yoo, Younsuck Koh
    The Korean Journal of Hospice and Palliative Care.2022; 25(1): 1.     CrossRef
  • Use of antimicrobial agents in actively dying inpatients after suspension of life-sustaining treatments: Suggestion for antimicrobial stewardship
    Dayeong Kim, Subin Kim, Kyoung Hwa Lee, Sang Hoon Han
    Journal of Microbiology, Immunology and Infection.2022; 55(4): 651.     CrossRef
  • Will implementation of the Life-sustaining Treatment Decisions Act reduce the incidence of cardiopulmonary resuscitation?
    In-Ae Song
    Acute and Critical Care.2022; 37(2): 256.     CrossRef
  • Changes in the incidence of cardiopulmonary resuscitation before and after implementation of the Life-Sustaining Treatment Decisions Act
    Hyunjae Im, Hyun Woo Choe, Seung-Young Oh, Ho Geol Ryu, Hannah Lee
    Acute and Critical Care.2022; 37(2): 237.     CrossRef
  • Aggressiveness of care in the last days of life in the emergency department of a tertiary hospital in Korea
    Jung Sun Kim, Sun Young Lee, Min Sung Lee, Shin Hye Yoo, Jeongmi Shin, Wonho Choi, Yejin Kim, Hyung Sook Han, Jinui Hong, Bhumsuk Keam, Dae Seog Heo
    BMC Palliative Care.2022;[Epub]     CrossRef
  • The Medical Needs and Characteristics of Cancer and Progressive Neurologic Disease Patients Who Use Home-Based Medical Care in Korea: A Retrospective Study for 2011-2020
    Yo Han Han, Shin Hye Yoo, Sun Young Lee, In Young Hwang, Kyae Hyung Kim, Belong Cho, Min Sun Kim, Wonho Choi, Yejin Kim
    Journal of the American Medical Directors Association.2022; 23(10): 1634.     CrossRef
  • Association of perceived life satisfaction with attitudes toward life-sustaining treatment among the elderly in South Korea: a cross-sectional study
    Il Yun, Hyunkyu Kim, Eun-Cheol Park, Suk-Yong Jang
    BMC Palliative Care.2022;[Epub]     CrossRef
  • Type of bystander and rate of cardiopulmonary resuscitation in nursing home patients suffering out-of-hospital cardiac arrest
    Seung Hyo Lee, Sun Young Lee, Jeong Ho Park, Kyoung Jun Song, Sang Do Shin
    The American Journal of Emergency Medicine.2021; 47: 17.     CrossRef
  • A National Study of Life-Sustaining Treatments in South Korea: What Factors Affect Decision-Making?
    So-Youn Park, Bomyee Lee, Jeong Yeon Seon, In-Hwan Oh
    Cancer Research and Treatment.2021; 53(2): 593.     CrossRef
  • Difficulties Doctors Experience during Life-Sustaining Treatment Discussion after Enactment of the Life-Sustaining Treatment Decisions Act: A Cross-Sectional Study
    Shin Hye Yoo, Wonho Choi, Yejin Kim, Min Sun Kim, Hye Yoon Park, Bhumsuk Keam, Dae Seog Heo
    Cancer Research and Treatment.2021; 53(2): 584.     CrossRef
  • Family Members' Knowledge and Attitude Toward Life-Sustaining Treatment Decisions for Patients in the Intensive Care Unit
    Sunjung Kim, Sunghee H. Tak
    Journal of Hospice & Palliative Nursing.2021; 23(3): 256.     CrossRef
  • Changes in decision-making process for life-sustaining treatment in patients with advanced cancer after the life-sustaining treatment decisions-making act
    Hyeyeong Kim, Hyeon-Su Im, Kyong Og Lee, Young Joo Min, Jae-Cheol Jo, Yunsuk Choi, Yoo Jin Lee, Daseul Kang, Changyoung Kim, Su-Jin Koh, Jaekyung Cheon
    BMC Palliative Care.2021;[Epub]     CrossRef
  • Life-Sustaining Treatment States in Korean Cancer Patients after Enforcement of Act on Decisions on Life-Sustaining Treatment for Patients at the End of Life
    Young-Woong Won, Hwa Jung Kim, Jung Hye Kwon, Ha Yeon Lee, Sun Kyung Baek, Yu Jung Kim, Do Yeun Kim, Hyewon Ryu
    Cancer Research and Treatment.2021; 53(4): 908.     CrossRef
  • The Situation of Life-Sustaining Treatment One Year after Enforcement of the Act on Decisions on Life-Sustaining Treatment for Patients at the End-of-Life in Korea: Data of National Agency for Management of Life-Sustaining Treatment
    Ha Yeon Lee, Hwa Jung Kim, Jung Hye Kwon, Sun Kyung Baek, Young-Woong Won, Yu Jung Kim, Su Jin Baik, Hyewon Ryu
    Cancer Research and Treatment.2021; 53(4): 897.     CrossRef
  • Preparation and Practice of the Necessary Documents in Hospital for the “Act on Decision of Life-Sustaining Treatment for Patients at the End-of-Life”
    Sun Kyung Baek, Hwa Jung Kim, Jung Hye Kwon, Ha Yeon Lee, Young-Woong Won, Yu Jung Kim, Sujin Baik, Hyewon Ryu
    Cancer Research and Treatment.2021; 53(4): 926.     CrossRef
  • Current Status and Cardinal Features of Patient Autonomy after Enactment of the Life-Sustaining Treatment Decisions Act in Korea
    Hwa Jung Kim, Yu Jung Kim, Jung Hye Kwon, Young-Woong Won, Ha Yeon Lee, Sun Kyung Baek, Hyewon Ryu, Do Yeun Kim
    Cancer Research and Treatment.2021; 53(4): 917.     CrossRef
  • Hospice and Palliative Care Education for Medical Students in Korea
    Do Yeun Kim, Soon Nam Lee
    Korean Medical Education Review.2020; 22(3): 146.     CrossRef
  • 10,044 View
  • 237 Download
  • 30 Web of Science
  • 33 Crossref
Close layer
Changes of End of Life Practices for Cancer Patients and Their Association with Hospice Palliative Care Referral over 2009-2014: A Single Institution Study
Hyun Jung Jho, Eun Jung Nam, Il Won Shin, Sun Young Kim
Cancer Res Treat. 2020;52(2):419-425.   Published online September 3, 2019
DOI: https://doi.org/10.4143/crt.2018.648
AbstractAbstract PDFPubReaderePub
Purpose
In Korea, hospice palliative care (HPC) provision for cancer patients has increased recently. However, whether end of life (EoL) care practices have improved along with the development of HPC is unclear. We intended to investigate the changes in EoL care practices and their association with HPC referral. Materials and Methods Retrospective medical record review of adult cancer patients who died at National Cancer Center Korea from 1 January 2009 to 31 December 2014 was performed. Changes of EoL practices including chemotherapy within 2 weeks from death, death in intensive care unit (ICU), documentation of “do not resuscitate (DNR)” within 7 days from death and referral to HPC from 2009 to 2014 were analyzed as well as the association between referral to HPC and other practices.
Results
A total of 2,377 cases were included in the analysis. Between 2009 and 2014, referral to HPC increased and DNR documentation within 7 days from death decreased significantly. Cases for chemotherapy within 2 weeks from death and death in ICU didn’t change over the study period. Patients referred to HPC were less likely to receive chemotherapy within 2 weeks from death, die in ICU and document DNR within 7 days from death. Conclusion During the study period, EoL practices among cancer patients partly changed toward less aggressive in our institution. HPC referral was associated with less aggressive cancer care at the EoL. Policies to promote EoL discussion are necessary to improve the EoL practices of cancer patients.

Citations

Citations to this article as recorded by  
  • Decreased aggressive care at the end of life among advanced cancer patients in the Republic of Korea: a nationwide study from 2012 to 2018
    Sara Kwon, Kyuwoong Kim, Bohyun Park, So-Jung Park, Hyun Jung Jho, Jin Young Choi
    BMC Palliative Care.2024;[Epub]     CrossRef
  • Symptom burden, palliative care knowledge, and palliative care needs in advanced gynecological cancer patients in Korea
    Eungil Ko, Yaelim Lee
    Supportive Care in Cancer.2024;[Epub]     CrossRef
  • End-of-Life Decision Making in Patients with Advanced Dementia: The Perspectives of the Korean General Population and Clinicians
    So Yeon Jeon, Shin Hye Yoo, Jung Lee, In Gyu Song, Min Sun Kim, Hye Yoon Park
    Psychiatry Investigation.2024; 21(10): 1137.     CrossRef
  • Advance Care Planning in South Korea
    Yu Jung Kim, Sun-Hyun Kim
    Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen.2023; 180: 68.     CrossRef
  • Public awareness of advance care planning and hospice palliative care: a nationwide cross-sectional study in Korea
    Boram Kim, Junyong Lee, Youn Seon Choi
    BMC Palliative Care.2023;[Epub]     CrossRef
  • Prevalence and related factors of do-not-resuscitate orders among in-hospital cardiac arrest patients
    Tangxing Jiang, Yanyan Ma, Jiaqi Zheng, Chunyi Wang, Kai Cheng, Chuanbao Li, Feng Xu, Yuguo Chen
    Heart & Lung.2022; 51: 9.     CrossRef
  • Discussing POLST-facilitated hospice care enrollment in patients with terminal cancer
    Ho Jung An, Hyun Jeong Jeon, Sang Hoon Chun, Hyun Ae Jung, Hee Kyung Ahn, Kyung Hee Lee, Min-ho Kim, Ju Hee Kim, Jaekyung Cheon, Su-Jin Koh
    Supportive Care in Cancer.2022; 30(9): 7431.     CrossRef
  • A National Study of Life-Sustaining Treatments in South Korea: What Factors Affect Decision-Making?
    So-Youn Park, Bomyee Lee, Jeong Yeon Seon, In-Hwan Oh
    Cancer Research and Treatment.2021; 53(2): 593.     CrossRef
  • Difficulties Doctors Experience during Life-Sustaining Treatment Discussion after Enactment of the Life-Sustaining Treatment Decisions Act: A Cross-Sectional Study
    Shin Hye Yoo, Wonho Choi, Yejin Kim, Min Sun Kim, Hye Yoon Park, Bhumsuk Keam, Dae Seog Heo
    Cancer Research and Treatment.2021; 53(2): 584.     CrossRef
  • Changes in decision-making process for life-sustaining treatment in patients with advanced cancer after the life-sustaining treatment decisions-making act
    Hyeyeong Kim, Hyeon-Su Im, Kyong Og Lee, Young Joo Min, Jae-Cheol Jo, Yunsuk Choi, Yoo Jin Lee, Daseul Kang, Changyoung Kim, Su-Jin Koh, Jaekyung Cheon
    BMC Palliative Care.2021;[Epub]     CrossRef
  • Consent for withholding life-sustaining treatment in cancer patients: a retrospective comparative analysis before and after the enforcement of the Life Extension Medical Decision law
    Yu Jin Chung, Incheol Park, Junho Cho, Jin Ho Beom, Ji Eun Lee
    BMC Medical Ethics.2021;[Epub]     CrossRef
  • Implication of the Life-Sustaining Treatment Decisions Act on End-of-Life Care for Korean Terminal Patients
    Jung Sun Kim, Shin Hye Yoo, Wonho Choi, Yejin Kim, Jinui Hong, Min Sun Kim, Hye Yoon Park, Bhumsuk Keam, Dae Seog Heo
    Cancer Research and Treatment.2020; 52(3): 917.     CrossRef
  • 6,274 View
  • 176 Download
  • 13 Web of Science
  • 12 Crossref
Close layer
The Effect of Hospice Consultation on Aggressive Treatment of Lung Cancer
Shin Hye Yoo, Bhumsuk Keam, Miso Kim, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo
Cancer Res Treat. 2018;50(3):720-728.   Published online July 14, 2017
DOI: https://doi.org/10.4143/crt.2017.169
AbstractAbstract PDFPubReaderePub
Purpose
The aims of this study were to investigate trends of aggressive treatment of non-small cell lung cancer (NSCLC) patients at the end-of-life (EOL) during the recent 5 years and examine the relationship between hospice consultation (HC) and aggressive care.
Materials and Methods
The medical records of 789 patients with stage IIIB-IV NSCLC at Seoul National University Hospital (SNUH) who received palliative chemotherapy and died from 2010 to 2014 were retrospectively reviewed. Indicators of aggressive treatment were evaluated, and the association of HC with these indicators was analyzed.
Results
During the last 5 years, the frequency of HC increased from 26.7% to 43.6%. The time interval from last chemotherapy to death increased, and the proportion of patients who received palliative chemotherapy, visited an emergency room, were admitted to intensive care unit, during the last month of life, and died in SNUH significantly decreased over time. Referral to HC was significantly associated with lower intensive care unit admission rates, lower out-of-hospital death rates, and less use of the chemotherapy within 1 month prior to death. Overall survival did not differ by HC.
Conclusion
The pattern of cancer care nearthe EOL has become less aggressivewhen HCwas provided. The positive association of HCwith better EOL care suggests that providing HC at the optimal time might help to avoid futile aggressive treatment.

Citations

Citations to this article as recorded by  
  • Hospice delivery models and survival differences in the terminally ill: a large cohort study
    Wei-Shu Lai, I-Ting Liu, Jui-Hung Tsai, Pei-Fang Su, Pin-Hsuan Chiu, Ying-Tzu Huang, Ge-Lin Chiu, Yu-Yeh Chen, Peng-Chan Lin
    BMJ Supportive & Palliative Care.2024; 14(e1): e1134.     CrossRef
  • Use of high‐flow nasal cannula oxygen therapy for patients with terminal cancer at the end of life
    Jung Sun Kim, Jeongmi Shin, Nam Hee Kim, Sun Young Lee, Shin Hye Yoo, Bhumsuk Keam, Dae Seog Heo
    Cancer Medicine.2023; 12(13): 14612.     CrossRef
  • Antibiotic prescription patterns during last days of hospitalized patients with advanced cancer: the role of palliative care consultation
    Jeong-Han Kim, Shin Hye Yoo, Bhumsuk Keam, Dae Seog Heo
    Journal of Antimicrobial Chemotherapy.2023; 78(7): 1694.     CrossRef
  • Discussing POLST-facilitated hospice care enrollment in patients with terminal cancer
    Ho Jung An, Hyun Jeong Jeon, Sang Hoon Chun, Hyun Ae Jung, Hee Kyung Ahn, Kyung Hee Lee, Min-ho Kim, Ju Hee Kim, Jaekyung Cheon, Su-Jin Koh
    Supportive Care in Cancer.2022; 30(9): 7431.     CrossRef
  • Perceptions on the current content and pedagogical approaches used in end-of-life care education among undergraduate nursing students: a qualitative, descriptive study
    Wenjing Cao, Chunyan Li, Qianqian Zhang, Huiru Tong
    BMC Medical Education.2022;[Epub]     CrossRef
  • Increased in-hospital mortality and emergent cases in patients with stage IV cancer
    Elleana J. Majdinasab, Yana Puckett, Kevin Y. Pei
    Supportive Care in Cancer.2021; 29(6): 3201.     CrossRef
  • Changes of End of Life Practices for Cancer Patients and Their Association with Hospice Palliative Care Referral over 2009-2014: A Single Institution Study
    Hyun Jung Jho, Eun Jung Nam, Il Won Shin, Sun Young Kim
    Cancer Research and Treatment.2020; 52(2): 419.     CrossRef
  • Implication of the Life-Sustaining Treatment Decisions Act on End-of-Life Care for Korean Terminal Patients
    Jung Sun Kim, Shin Hye Yoo, Wonho Choi, Yejin Kim, Jinui Hong, Min Sun Kim, Hye Yoon Park, Bhumsuk Keam, Dae Seog Heo
    Cancer Research and Treatment.2020; 52(3): 917.     CrossRef
  • Do advance directive attitudes and perceived susceptibility and end-of-life life-sustaining treatment preferences between patients with heart failure and cancer differ?
    JinShil Kim, Jiin Choi, Mi-Seung Shin, Miyeong Kim, EunJu Seo, Minjeong An, Jae Lan Shim, Seongkum Heo, Hans-Peter Brunner-La Rocca
    PLOS ONE.2020; 15(9): e0238567.     CrossRef
  • Duration of palliative care before death in international routine practice: a systematic review and meta-analysis
    Roberta I. Jordan, Matthew J. Allsop, Yousuf ElMokhallalati, Catriona E. Jackson, Helen L. Edwards, Emma J. Chapman, Luc Deliens, Michael I. Bennett
    BMC Medicine.2020;[Epub]     CrossRef
  • Relationship Between Preferences for Advance Directive Treatments and Decisional Conflicts Among Low-Income, Home-Based Cancer Management Recipients in Korea
    Miyeong Kim, Seongkum Heo, Jung-Yi Hur, JaeLan Shim, JinShil Kim
    Journal of Transcultural Nursing.2019; 30(6): 587.     CrossRef
  • Factors associated with early mortality in non-small cell lung cancer patients following systemic anti-cancer therapy: A 10 year population-based study
    Amanda J.W. Gibson, Haocheng Li, Adrijana D’Silva, Anifat A. Elegbede, Roxana A. Tudor, Shannon Otsuka, D. Gwyn Bebb, Winson Y. Cheung
    Lung Cancer.2019; 134: 141.     CrossRef
  • Interventions to reduce aggressive care at end of life among patients with cancer: a systematic review
    Nauzley C Abedini, Rachel K Hechtman, Achintya D Singh, Rafina Khateeb, Jason Mann, Whitney Townsend, Vineet Chopra
    The Lancet Oncology.2019; 20(11): e627.     CrossRef
  • Demographic and Socioeconomic Factors for Renouncing Further Active Therapy for Patients with Brain Metastasis of Non-Small Cell Lung Cancer
    Gyuseo Jung, Seok-Hyun Kim, Tae Gyu Kim, Young Zoon Kim
    Brain Tumor Research and Treatment.2019; 7(2): 112.     CrossRef
  • 9,642 View
  • 261 Download
  • 16 Web of Science
  • 14 Crossref
Close layer
Special Article
Development of a Community-Based Palliative Care Model for Advance Cancer Patients in Public Health Centers in Busan, Korea
Sook-Nam Kim, Soon-Ock Choi, Seong Hoon Shin, Ji-Sun Ryu, Jeong-Won Baik
Cancer Res Treat. 2017;49(3):559-568.   Published online October 18, 2016
DOI: https://doi.org/10.4143/crt.2016.276
AbstractAbstract PDFPubReaderePub
Purpose
A feasible palliative care model for advance cancer patients is needed in Korea with its rapidly aging population and corresponding increase in cancer prevalence. This study describes the process involved in the development of a community-based palliative care (CBPC) model implemented originally in a Busan pilot project.
Materials and Methods
The model development included steps I and II of the pilot project, identification of the service types, a survey exploring the community demand for palliative care, construction of an operational infrastructure, and the establishment of a service delivery system. Public health centers (including Busan regional cancer centers, palliative care centers, and social welfare centers) served as the regional hubs in the development of a palliative care model.
Results
The palliative care project included the provision of palliative care, establishment of a support system for the operations, improvement of personnel capacity, development of an educational and promotional program, and the establishment of an assessment system to improve quality. The operational infrastructure included a service management team, provision teams, and a support team. The Busan Metropolitan City CBPC model was based on the principles of palliative care as well as the characteristics of public health centers that implemented the community health projects.
Conclusion
The potential use of the Busan CBPC model in Korea should be explored further through service evaluations.

Citations

Citations to this article as recorded by  
  • Palliative Care for Cancer Patients in Asia: Challenges and Countermeasures
    Yu Wang, Xinqing Zhang, Yilin Huang, Xiangyu Ma
    Oncology Reviews.2024;[Epub]     CrossRef
  • The contribution of the nursing profession to the establishment of social justice: A grounded theory study
    Fariba Hosseinzadegan, Hosein Habibzadeh, Madineh Jasemi
    Nursing Ethics.2024; 31(5): 759.     CrossRef
  • Exploring caregivers’ perceptions of community-based service requirements of patients with spinal cord injury: a qualitative study
    Nasrin Galehdar, Heshmatolah Heydari
    BMC Primary Care.2023;[Epub]     CrossRef
  • Perception about Home Visiting Hospice Service of End of Life Patients at Home
    So Young Kim
    Journal of Korean Association for Qualitative Research.2023; 8(2): 153.     CrossRef
  • A Review of Palliative Care Service Delivery Models and Patient Outcomes for Adults with Cancer in Selected East and Southeast Asian Countries
    Chun-Yi Tseng, Natalia Calanzani
    International Journal of Medical Students.2023; 11(4): 294.     CrossRef
  • Developing an integrated model of community-based palliative care into the primary health care (PHC) for terminally ill cancer patients in Iran
    Suzanne Hojjat-Assari, Maryam Rassouli, Maxwell Madani, Heshmatolah Heydari
    BMC Palliative Care.2021;[Epub]     CrossRef
  • Structure and process of palliative care provision: a nationwide study of public hospitals in Thailand
    Parichat Dokmai, Natthani Meemon, Seung Chun Paek, Supakarn Tayjasanant
    BMC Health Services Research.2021;[Epub]     CrossRef
  • Community Care for Cancer Patients in Rural Areas: An Integrated Regional Cancer Center and Public Health Center Partnership Model
    Jung Hun Kang, Chang Yoon Jung, Ki-Soo Park, Jung Sik Huh, Sung Yong Oh, Jung Hye Kwon
    The Korean Journal of Hospice and Palliative Care.2021; 24(4): 226.     CrossRef
  • Differences in medical costs for end-of-life patients receiving traditional care and those receiving hospice care: A retrospective study
    Ya-Ting Huang, Ying-Wei Wang, Chou-Wen Chi, Wen-Yu Hu, Rung Lin, Chih-Chung Shiao, Woung-Ru Tang, Chun Chieh Yeh
    PLOS ONE.2020; 15(2): e0229176.     CrossRef
  • Exploring health care providers’ perceptions about home-based palliative care in terminally ill cancer patients
    Heshmatolah Heydari, Suzanne Hojjat-Assari, Mohammad Almasian, Pooneh Pirjani
    BMC Palliative Care.2019;[Epub]     CrossRef
  • Structural Analysis on Quality of Life for Terminal Cancer Patients provided Hospice and Palliative Care Services in Community Health Centers
    Sook-Nam Kim, Soon-Ock Choi, Ji-Seon Ryu, Jung-Rim Kim
    The Korean Journal of Health Service Management.2019; 13(4): 163.     CrossRef
  • Evaluation of Outcomes of the Busan Community-based Palliative Care Project in Korea
    Soon-Ock Choi, Sook-Nam Kim, Seong-Hoon Shin, Ji-Seon Ryu, Jeong-Won Baik, Jung-Rim Kim, Nae-Hyeon Kim
    Asian Nursing Research.2018; 12(4): 286.     CrossRef
  • 10,826 View
  • 380 Download
  • 11 Web of Science
  • 12 Crossref
Close layer
Original Articles
Do Korean Doctors Think a Palliative Consultation Team Would Be Helpful to Their Terminal Cancer Patients?
Hye-Young Shim, Yoon Jung Chang, Kiu-Sang Kawk, Tran Thi Xuan Mai, Jin Young Choi, Eun Mi Ahn, Hyun Jung Jho, So-Jung Park
Cancer Res Treat. 2017;49(2):437-445.   Published online August 10, 2016
DOI: https://doi.org/10.4143/crt.2015.495
AbstractAbstract PDFPubReaderePub
Purpose
Hospice and palliative care services (HPC) are not commonly utilized in Korea; however, palliative care teams (PCTs) have been found to be effective at addressing the shortcomings in HPC. In this study, we attempted to outline unmet palliative care needs of terminal cancer patients and the potential benefits of PCTs as perceived by doctors in Korea.
Materials and Methods
We surveyed 474 doctors at 10 cancer-related academic conferences from June to November 2014 with a self-report questionnaire to assess their perceptions of end-of-life care needs and the expected effects of PCTs on caring for terminal cancer patients. Among those surveyed, 440 respondents who completed the entire questionnaire were analyzed.
Results
In all domains, fewer participants reported satisfaction with palliative care services than those reporting needs (p < 0.001). The surveyed participants also reported difficulties with a shortage of time for treatment, psychological burden, lack of knowledge regarding hospice care, lengths of stay, and palliative ward availability. Multivariate logistic regression analysis revealed that female doctors (odds ratio [OR], 2.672; 95% confidence interval [CI], 1.035 to 6.892), doctors who agreed that referring my patients to a HPC means I must give up on my patient (OR, 3.075; 95% CI, 1.324 to 7.127), and doctors who had no experience with HPC education (OR, 3.337; 95% CI, 1.600 to 7.125) were associated with higher expected effectiveness of PCT activities.
Conclusion
The PCT activities were expected to fill the doctor’s perceived unmet HPC needs of terminal cancer patients and difficulties in communications.

Citations

Citations to this article as recorded by  
  • Effects of tertiary palliative care on the pattern of end‐of‐life care in patients with hematologic malignancies in Korea
    Dong Hyun Kim, Jeonghwan Youk, Ja Min Byun, Youngil Koh, Junshik Hong, Tae Min Kim, Inho Kim, Sung‐Soo Yoon, Shin Hye Yoo, Dong‐Yeop Shin
    European Journal of Haematology.2024; 112(5): 743.     CrossRef
  • Development and validation of impact of early integration of palliative care and oncology(IEI PCO) questionnaire: a survey for medical oncologists and nurses
    Abdulrahman Abdulaziz Abdullah, Wafaa Mostafa Abd-El-Gawad, Sobhi Mostafa AboSerea, Fatma AbdelShakor Ali, Saima Ali
    BMC Palliative Care.2024;[Epub]     CrossRef
  • Patients’ Dying Process From the Point of View of Family and Hospice Team: A Qualitative Exploration of Family Member and Hospice Team Experiences With Hospice in Korea
    Sooyoun K. Han, Yugyeong Eo
    OMEGA - Journal of Death and Dying.2022; 86(2): 533.     CrossRef
  • Status of palliative care education in Mainland China: A systematic review
    Antonia M. Willemsen, Stephen Mason, Silja Zhang, Frank Elsner
    Palliative and Supportive Care.2021; 19(2): 235.     CrossRef
  • Effectiveness of home hospice care: a nationwide prospective observational study
    Eunmi Ahn, In Gyu Song, Jin Young Choi, Hyun Jung Jho, Ilyeon Park, Suah Sung, Seohyun Shin, So Jung Park, Eun Jung Nam, Sung Hoon Jeong, Yoon Jung Chang
    Supportive Care in Cancer.2020; 28(6): 2713.     CrossRef
  • Sedation for terminally ill cancer patients
    Young Saing Kim, Haa-Na Song, Jin Seok Ahn, Su-Jin Koh, Jun Ho Ji, In Gyu Hwang, Jina Yun, Jung Hye Kwon, Jung Hun Kang
    Medicine.2019; 98(5): e14278.     CrossRef
  • 10,314 View
  • 168 Download
  • 6 Web of Science
  • 6 Crossref
Close layer
Frequency and Outcome of Neuroleptic Rotation in the Management of Delirium in Patients with Advanced Cancer
Seong Hoon Shin, David Hui, Gary Chisholm, Jung Hun Kang, Julio Allo, Janet Williams, Eduardo Bruera
Cancer Res Treat. 2015;47(3):399-405.   Published online November 24, 2014
DOI: https://doi.org/10.4143/crt.2013.229
AbstractAbstract PDFPubReaderePub
Purpose
The response to haloperidol as a first-line neuroleptic and the pattern of neuroleptic rotation after haloperidol failure have not been well defined in palliative care. The purpose of this study was to determine the efficacy of haloperidol as a first-line neuroleptic and the predictors associated with the need to rotate to a second neuroleptic. Materials and Methods We conducted a retrospective review of the charts of advanced cancer patients admitted to our acute palliative care unit between January 2012 and March 2013. Inclusion criteria were a diagnosis of delirium and first-line treatment with haloperidol. Results Among 167 patients with delirium, 128 (77%) received only haloperidol and 39 (23%) received a second neuroleptic. Ninety-one patients (71%) who received haloperidol alone improved and were discharged alive. The median initial haloperidol dose was 5 mg (interquartile ranges [IQR], 3 to 7 mg) and the median duration was 5 days (IQR, 3 to 7 days). The median final haloperidol dose was 6 mg (IQR, 5 to 7 mg). A lack of treatment efficacy was the most common reason for neuroleptic rotation (87%). Significant factors associated with neuroleptic rotation were inpatient mortality (59% vs. 29%, p=0.001), and being Caucasian (87% vs. 62%, p=0.014). Chlorpromazine was administered to 37 patients (95%) who were not treated successfully by haloperidol. The median initial chlorpromazine dose was 150 mg (IQR, 100 to 150 mg) and the median duration was 3 days (IQR, 2 to 6 days). Thirteen patients (33%) showed reduced symptoms after the second neuroleptic. Conclusion Neuroleptic rotation from haloperidol was only required in 23% of patients with delirium and was associated with inpatient mortality and white race.

Citations

Citations to this article as recorded by  
  • Naming racism as a root cause of inequities in palliative care research: a scoping review
    Kavita Algu, Joshua Wales, Michael Anderson, Mariam Omilabu, Thandi Briggs, Allison M. Kurahashi
    BMC Palliative Care.2024;[Epub]     CrossRef
  • Management of Physical Symptoms in Patients with Advanced Cancer during the Last Weeks and Days of Life
    Ahsan Azhar, David Hui
    Cancer Research and Treatment.2022; 54(3): 661.     CrossRef
  • Chlorpromazine as Treatment for Refractory Agitation Associated with Pediatric Delirium
    Shin Young Kim, Shari Simone, Omayma A. Kishk, Ana Lia Graciano, Hyunuk Seung, Sarah Edwards
    The Journal of Pediatric Pharmacology and Therapeutics.2022; 27(8): 725.     CrossRef
  • Pharmacological and non-pharmacological treatment of delirium in an oncological hospital service: an integrative review
    Luciana Aparecida Vieira Louro, João Francisco Possari, Antônio Fernandes Costa Lima
    Revista Brasileira de Enfermagem.2021;[Epub]     CrossRef
  • Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial
    David Hui, Allison De La Rosa, Annie Wilson, Thuc Nguyen, Jimin Wu, Marvin Delgado-Guay, Ahsan Azhar, Joseph Arthur, Daniel Epner, Ali Haider, Maxine De La Cruz, Yvonne Heung, Kimberson Tanco, Shalini Dalal, Akhila Reddy, Janet Williams, Sapna Amin, Terri
    The Lancet Oncology.2020; 21(7): 989.     CrossRef
  • A Scoping Review to Map Empirical Evidence Regarding Key Domains and Questions in the Clinical Pathway of Delirium in Palliative Care
    Peter G. Lawlor, Nicole A. Rutkowski, Alistair R. MacDonald, Mohammed T. Ansari, Lindsey Sikora, Franco Momoli, Salmaan Kanji, David K. Wright, Erin Rosenberg, Annmarie Hosie, Jose L. Pereira, David Meagher, Jill Rice, John Scott, Shirley H. Bush
    Journal of Pain and Symptom Management.2019; 57(3): 661.     CrossRef
  • Prevalencia de delirium mediante la escala Memorial Delirium Assessment Scale (MDAS) en pacientes oncológicos avanzados ingresados en una Unidad de Cuidados Paliativos. Factores de riesgo, reversibilidad y tratamiento recibido
    Verónica Díaz García, Miriam López Pérez, Yolanda Zuriarrain Reyna
    Medicina Paliativa.2018; 25(4): 245.     CrossRef
  • Clinical Assessment and Management of Delirium in the Palliative Care Setting
    Shirley Harvey Bush, Sallyanne Tierney, Peter Gerard Lawlor
    Drugs.2017; 77(15): 1623.     CrossRef
  • Delirium Management: Diagnosis, Assessment, and Treatment in Palliative Care
    Min Seok Seo, Yong Joo Lee
    The Korean Journal of Hospice and Palliative Care.2016; 19(3): 201.     CrossRef
  • Neuroleptics in the management of delirium in patients with advanced cancer
    David Hui, Rony Dev, Eduardo Bruera
    Current Opinion in Supportive & Palliative Care.2016; 10(4): 316.     CrossRef
  • Acute symptomatic complications among patients with advanced cancer admitted to acute palliative care units: A prospective observational study
    David Hui, Renata dos Santos, Suresh Reddy, Maria Salete de Angelis Nascimento, Donna S Zhukovsky, Carlos Eduardo Paiva, Shalini Dalal, Everaldo Donizeti Costa, Paul Walker, Heloisa Helena Scapulatempo, Rony Dev, Camila Souza Crovador, Maxine De La Cruz,
    Palliative Medicine.2015; 29(9): 826.     CrossRef
  • 12,349 View
  • 98 Download
  • 12 Web of Science
  • 11 Crossref
Close layer
Case Reports
Metastatic Skin Lesions on Lower Extremities in a Patient with Recurrent Serous Papillary Ovarian Carcinoma: A Case Report and Literature Review
Moon-Kyung Kim, Seo-Hee Kim, Yoo-Young Lee, Chel Hun Choi, Tae-Joong Kim, Jeoung-Won Lee, Je-Ho Lee, Duk-Soo Bae, Byoung-Gie Kim
Cancer Res Treat. 2012;44(2):142-145.   Published online June 30, 2012
DOI: https://doi.org/10.4143/crt.2012.44.2.142
AbstractAbstract PDFPubReaderePub
Clinical observation of skin metastasis in ovarian cancer cases is relatively uncommon. And distant metastatic skin lesions including the extremities are much rarer still as most metastatic skin lesions are located in the skin in the abdominal wall adjacent to where the primary ovarian tumors exist. We report the case of a 60-year-old woman who presented skin lesions on both lower extremities as a consequence of the metastasis of serous papillary adenocarcinoma of the ovary. She presented with erythematous and painful cutaneous nodules on both upper legs and in the inguinal area 42 months after initial diagnosis of ovarian cancer. Skin biopsy revealed metastasis of adenocarcinoma in the dermis. She was treated with surgical excision and systemic chemotherapy. Literature review has suggested that a combined modality approach including surgical excision and chemotherapy may be useful in the management of skin metastases due to ovarian cancer.

Citations

Citations to this article as recorded by  
  • Skin metastasis from ovarian cancer with somatic BRCA1 mutation: A case report and literature review
    Jingheng Zhang, Wenfeng He, Zhenhua Zhang, Hui Dong, Xiangyu Deng, Qinglian Wen, Dan Li
    Oncology Letters.2024;[Epub]     CrossRef
  • Metastasis of ovarian cancer to nasal skin and skin on the trunk: a rare case report
    Chen Chen, Ouyang Yingyao, Xiang Yan, He Qianru, Wang Hong, Chen Chen, Yang Lei
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • A Rare and Sinister Presentation of Cutaneous Metastasis over Right Lower Limb in a Case of Ovarian Carcinoma
    Preema Sinha, Parul Kamboj, Anamika Sinha, Juhi Sharma
    Journal of Marine Medical Society.2022; 24(2): 211.     CrossRef
  • Clinicopathologic features of cutaneous metastases from internal malignancies
    Hyeong Mok Kwon, Gyu Yeong Kim, Dong Hoon Shin, Young Kyung Bae
    Journal of Pathology and Translational Medicine.2021; 55(4): 289.     CrossRef
  • Rare Sites Metastasis in Ovarian Carcinoma: a Compilation of 3 Case Reports
    Megha Nandwani, Debabrata Barmon, Dimpy Begum, Amal C. Kataki
    Indian Journal of Surgical Oncology.2020; 11(1): 150.     CrossRef
  • Cutaneous metastasis of PD-L1 positive ovarian carcinoma
    Victoria Hastings, Jennifer McEachron, Marguax J. Kanis
    Gynecologic Oncology Reports.2020; 33: 100607.     CrossRef
  • PET/CT for Evaluation of Ovarian Cancer
    Jukka Kemppainen, Johanna Hynninen, Johanna Virtanen, Marko Seppänen
    Seminars in Nuclear Medicine.2019; 49(6): 484.     CrossRef
  • Cutaneous Metastases in Ovarian Cancer
    Isao Otsuka
    Cancers.2019; 11(9): 1292.     CrossRef
  • Skin metastases in ovarian clear cell adenocarcinoma: a case report and a review of the literature
    Gina Nam, Young-mee Lim, Min Sun Cho, Junghye Lee, Yun Hwan Kim
    Obstetrics & Gynecology Science.2017; 60(6): 593.     CrossRef
  • Two independent incidences of skin metastases in the umbilicus and abdominal wall in ovarian serous adenocarcinoma
    Hongyan Cheng, Chunmei Gao, Runtong Zhang, Zhaojie Yang, Guiyu Zhang
    Medicine.2017; 96(49): e9118.     CrossRef
  • Cutaneous metastases from adenocarcinoma of the ovary
    Heidi H. McDonald, Milton R. Moore, Jeffrey J. Meffert
    JAAD Case Reports.2016; 2(5): 406.     CrossRef
  • Ovarian carcinoma presenting as cutaneous nasal metastasis
    Ana Marta António, João Vitor Alves, João Goulão, Elvira Bártolo
    Anais Brasileiros de Dermatologia.2016; 91(5 suppl 1): 101.     CrossRef
  • 11,907 View
  • 72 Download
  • 12 Crossref
Close layer
Recurrent and Metastatic Trichilemmal Carcinoma of the Skin Over the Thigh: A Case Report
Hyon Seung Yi, Sun Jin Sym, Jinny Park, Eun Kyung Cho, Seung-Yeon Ha, Dong Bok Shin, Jae Hoon Lee
Cancer Res Treat. 2010;42(3):176-179.   Published online September 30, 2010
DOI: https://doi.org/10.4143/crt.2010.42.3.176
AbstractAbstract PDFPubReaderePub

Trichilemmal carcinoma (TC) is an uncommon cutaneous neoplasm that develops from the external root sheath of the hair follicle. It is considered to be a low-grade carcinoma with low metastatic potential. Local recurrence and metastasis are rare after surgical excision. We report here on a case of metastatic TC in the skin over the thigh, and this tumor was treated with cisplatin and cyclophosphamide combination chemotherapy.

Citations

Citations to this article as recorded by  
  • Trichilemmal carcinoma metastatic to parotid gland: First report of fine needle aspiration cytology features
    Priya Jayakumar, Aanchal Kakkar, Sudheer Arava, Supriya Mallick
    Diagnostic Cytopathology.2024;[Epub]     CrossRef
  • Successful treatment of trichilemmal carcinoma with distant metastasis using pembrolizumab: a case report and review
    Lei Liu, Tengfei Long, Nannan Wei, Hongyan Zhang, Chaoliang Tang, Jin Gao
    Immunotherapy.2024; 16(10): 659.     CrossRef
  • A Rare Case of Trichilemmal Carcinoma of the Scalp
    Raymart Macasaet, FNU Arty, Janelle du Toit, Sai Gaddameedi, Shazia M Shah
    Cureus.2024;[Epub]     CrossRef
  • Malignant pilar cyst in a young woman: Case report and literature review
    Ali Ibrahim Ali Hegy, Amina Ibrahim El-yakub, Yaser Taha Sidahmed
    International Journal of Case Reports and Images.2024; 15(1): 89.     CrossRef
  • A Rare Case Of Trichilemmal Carcinoma In A Sun-unexposed Area
    Alemwosen Alem, Alazar Aregawi, Teketel Geremew
    Journal of Global Surgery (ONE).2024;[Epub]     CrossRef
  • Trichilemmal carcinoma treated by excision combined with photodynamic therapy: a case report and review of literature
    Lingyu Qidiao, Yilin Liu, Danni Hu, Xingchi Tao, Chunli Yao
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Systematic analysis and case series of the diagnosis and management of trichilemmal carcinoma
    Jiachen Sun, Lihua Zhang, Minglu Xiao, Shiyi Li, Runkai Chen, Ying Li, Yuguang Yang
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • When to sweat: A history of chemotherapy in malignant sweat gland tumors. A unique case report and literature review
    J. Matthiesen, R. Chiu, T. T. Do, S. Bamdad, J. Lee, S. K. Peng
    Clinical Case Reports.2023;[Epub]     CrossRef
  • Recurrent trichilemmal carcinoma of the periorbital region treated with IMRT radiotherapy: A case report and a review of literature
    Shan Gao, Qin Xu, Yanli Lan, Lang He
    Medicine.2023; 102(24): e34038.     CrossRef
  • Malignant proliferating trichilemmal tumor in abdominal wall: Report of a rare case at an uncommon site with literature review
    Mahdokht Azizi, Mazaher Ramezani
    Clinical Case Reports.2022;[Epub]     CrossRef
  • Trichilemmal Carcinoma of the Scalp in a Young Female: A Case Report
    Qiuyu Jia, Yunyan Yuan, Dandan Mao, Guangdong Wen, Xue Chen
    Clinical, Cosmetic and Investigational Dermatology.2022; Volume 15: 139.     CrossRef
  • Current Treatment Options for Cutaneous Adnexal Malignancies
    Hiroyuki Goto
    Current Treatment Options in Oncology.2022; 23(5): 736.     CrossRef
  • Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Follicular Differentiation
    Iga Płachta, Marcin Kleibert, Anna M. Czarnecka, Mateusz Spałek, Anna Szumera-Ciećkiewicz, Piotr Rutkowski
    International Journal of Molecular Sciences.2021; 22(9): 4759.     CrossRef
  • Huge Trichilemmal Carcinoma With Metastasis Presenting With Two Distinct Histological Morphologies: A Case Report
    Yao Xie, Lin Wang, Tingting Wang
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Trichilemmal carcinoma in a patient with squamous cell skin cancer
    V. A. Smolyannikova, M. A. Nefedova
    Arkhiv patologii.2019; 81(1): 31.     CrossRef
  • Locally aggressive trichilemmal carcinoma
    Ana María Maya-Rico, Catalina Jaramillo-Pulgarín, Ángela Londoño-García, Bibiana Peña-Zúñiga
    Anais Brasileiros de Dermatologia.2018; 93(4): 579.     CrossRef
  • Cells to Surgery Quiz: April 2018
    Ali Rajabi-Estarabadi, Sofia Iglesia, Jacob W. Griggs, Pooja Gurnani, Samuel C. Smith, Cassandra IF. Collins, Keyvan Nouri
    Journal of Investigative Dermatology.2018; 138(4): e37.     CrossRef
  • Adnexal Carcinomas Treated With Mohs Micrographic Surgery: A Comprehensive Review
    Stanislav N. Tolkachjov
    Dermatologic Surgery.2017; 43(10): 1199.     CrossRef
  • Malignant hair follicle tumors of the periorbital region: A review of literature and suggestion of a management guideline
    Paul Ikgan Sia, Edwin Figueira, Alexandra Allende, Dinesh Selva
    Orbit.2016; 35(3): 144.     CrossRef
  • Metastatic trichilemmal carcinoma in a patient with breast cancer
    Chrysis Sofianos, Nkhensani Y Chauke, Alexandra Grubnik
    BMJ Case Reports.2016; : bcr2016217661.     CrossRef
  • A Case of Trichilemmal Carcinoma With Distant Metastases in a Kidney Transplantation Patient
    K. Hiramatsu, K. Sasaki, M. Matsuda, M. Hashimoto, T. Eguchi, S. Tomikawa, T. Fujii, G. Watanabe
    Transplantation Proceedings.2015; 47(1): 155.     CrossRef
  • Challenges in the diagnosis of cutaneous adnexal tumours
    Richard Danialan, Kudakwashe Mutyambizi, Phyu P Aung, Victor G Prieto, Doina Ivan
    Journal of Clinical Pathology.2015; 68(12): 992.     CrossRef
  • Survival study and clinicopathological evaluation of trichilemmal carcinoma
    SHI-MIN ZHUANG, GE-HUA ZHANG, WEN-KUAN CHEN, SHU-WEI CHEN, LI-PING WANG, HUAN LI, MING SONG
    Molecular and Clinical Oncology.2013; 1(3): 499.     CrossRef
  • Unusual Invasion of Trichilemmal Umors: Two Case Reports
    Mehtap Karamese, Ahmet Akatekin, Malik Abaci, Zekeriya Tosun, Mustafa Keskin
    Modern Plastic Surgery.2012; 02(03): 54.     CrossRef
  • 9,910 View
  • 71 Download
  • 24 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP